+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
In Vivo Imaging Systems Market - Global Forecast 2026-2032- Product Image
In Vivo Imaging Systems Market - Global Forecast 2026-2032- Product Image
Sale

In Vivo Imaging Systems Market - Global Forecast 2026-2032

  • Report

  • 185 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6132422
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The In Vivo Imaging Systems Market is projected to reach USD 1.89 Billion in 2026. It is expected to continue growing at a CAGR of 12.68%, reaching USD 3.86 Billion by 2032.

In Vivo Imaging Systems: Executive Overview

In vivo imaging systems enable noninvasive or minimally invasive visualization of biological processes in living organisms. The field spans optical, magnetic resonance, ultrasound, nuclear, photoacoustic, and multimodal platforms used across preclinical research, translational studies, drug development, and selected clinical applications. Adoption is shaped by demand for longitudinal observation, improved disease-model characterization, earlier treatment assessment, and stronger links between laboratory findings and patient care.

How Multimodal Workflows Are Reshaping In Vivo Imaging

The landscape is shifting from standalone instruments toward integrated workflows that combine anatomical, functional, molecular, and temporal information. Higher-resolution detectors, improved probes, automated image reconstruction, and more standardized protocols are helping researchers obtain richer datasets while reducing procedural variability. Growing emphasis on reproducibility, animal-welfare considerations, interoperability, and quantitative endpoints is also influencing system selection and facility design.

Artificial Intelligence Is Expanding Imaging Utility

Artificial intelligence is being applied to image reconstruction, denoising, segmentation, registration, anomaly detection, longitudinal analysis, and experiment prioritization. These capabilities can shorten analysis cycles and help extract quantitative biomarkers from complex multimodal datasets, but their value depends on representative training data, transparent validation, robust metadata, and appropriate human oversight. Institutions are therefore pairing AI deployment with governance for model performance, data security, bias monitoring, and reproducibility.

Regional Insights Across the Global Imaging Landscape

North America benefits from established biomedical research infrastructure, advanced translational programs, and strong demand for quantitative imaging. Europe emphasizes collaborative research, regulatory rigor, harmonized data practices, and animal-welfare standards. Asia-Pacific is supported by expanding life-science capacity, rising investment in research infrastructure, and growing demand for advanced laboratory automation. Latin America is developing through academic centers, public-health research, and selective modernization of imaging facilities. The Middle East is strengthening specialized research and healthcare capabilities, while Africa shows opportunity through capacity building, collaborative networks, and targeted deployment suited to local infrastructure conditions.

Group-Level Priorities: ASEAN, BRICS, EU, G7, GCC, and NATO

ASEAN’s priorities include strengthening research connectivity, improving access to specialized equipment, and developing regional expertise. BRICS economies are advancing domestic research capacity while seeking broader collaboration and technology access. The European Union places particular weight on cross-border research, data governance, standardization, and responsible use. G7 members generally emphasize high-performance research, translational validation, and advanced digital infrastructure. GCC countries are investing in scientific and healthcare capabilities, including specialized facilities and talent development. NATO members, viewed through a broader resilience and dual-use technology lens, prioritize secure infrastructure, interoperability, and continuity of critical research capabilities.

Country-Level Dynamics Across Major Research Markets

The United States and Canada combine mature research ecosystems with demand for advanced, quantitative, and multimodal imaging. Germany, France, Italy, Spain, and the United Kingdom are supported by strong academic, pharmaceutical, and clinical-research networks, with regulation and reproducibility remaining important considerations. China, Japan, South Korea, India, and Australia are expanding capabilities through investment in biomedical science, engineering, and digital research infrastructure. Brazil, Mexico, and Russia reflect varied levels of institutional capacity and modernization, creating demand for adaptable systems, technical training, and service support aligned with local research priorities.

Actions for Leaders Building Resilient Imaging Programs

Industry leaders should align system design with clearly defined biological questions rather than selecting modalities in isolation. Priorities include modular multimodal architectures, open data interfaces, validated quantitative workflows, cybersecurity controls, and training that covers both acquisition and analysis. Partnerships with research institutions can improve protocol validation and application development, while lifecycle service models can support uptime, calibration, compliance, and user retention. AI initiatives should begin with high-value, well-curated use cases and include independent validation, documentation, and human review.

Research Methodology for the Executive Summary

This summary uses a structured review of the in vivo imaging systems domain, organizing insights by technology evolution, workflow adoption, artificial-intelligence applications, geography, economic groupings, and country context. Interpretation focuses on observable drivers such as research-infrastructure development, translational requirements, regulatory expectations, data practices, and system interoperability. Findings are presented qualitatively and exclude market estimates, market sizing, market shares, forecasts, and company-specific claims.

Conclusion: Building More Quantitative and Connected Imaging Ecosystems

In vivo imaging systems are becoming central to research programs that require longitudinal, multidimensional, and reproducible evidence from living subjects. Progress will depend not only on advances in hardware, but also on interoperable software, validated biomarkers, responsible AI, skilled personnel, and infrastructure suited to regional conditions. Organizations that connect imaging strategy with experimental design, data governance, and translational objectives will be better positioned to convert complex images into dependable scientific insight.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. In Vivo Imaging Systems Market, by Product Type
7.1. Introduction
7.2. Imaging Systems
7.2.1. Standalone Systems
7.2.2. Integrated Multimodal Systems
7.2.3. Portable And Benchtop Systems
7.3. Imaging Reagents And Probes
7.3.1. Optical Probes
7.3.1.1. Fluorescent Dyes
7.3.1.2. Bioluminescent Substrates
7.3.1.3. Targeted Molecular Probes
7.3.1.4. Activatable Probes
7.3.2. Nuclear Tracers
7.3.2.1. PET Tracers
7.3.2.2. SPECT Tracers
7.3.3. MRI Contrast Agents
7.3.4. CT Contrast Agents
7.3.5. Ultrasound Contrast Agents
7.4. Software
7.4.1. Image Acquisition Software
7.4.2. Image Analysis Software
7.4.2.1. 2D Analysis Tools
7.4.2.2. 3D Reconstruction Tools
7.4.2.3. Quantification And Kinetic Modeling
7.4.3. Data Management And Reporting Software
8. In Vivo Imaging Systems Market, by Technology
8.1. Introduction
8.2. Computed Tomography
8.2.1. Cone Beam CT
8.2.2. Micro CT
8.3. Magnetic Resonance Imaging
8.3.1. Fluorine MRI
8.3.2. Proton MRI
8.4. Optical Imaging
8.4.1. Bioluminescence Imaging
8.4.2. Fluorescence Imaging
8.5. Positron Emission Tomography
8.6. Ultrasound
9. In Vivo Imaging Systems Market, by Application
9.1. Introduction
9.2. Cardiology
9.2.1. Myocardial Infarction
9.2.2. Vascular Diseases
9.3. Drug Discovery
9.3.1. Pharmacokinetics
9.3.2. Target Validation
9.4. Neurology
9.4.1. Neurodegenerative Disease
9.4.2. Neuroinflammation
9.5. Oncology
9.5.1. Tumor Detection
9.5.2. Tumor Monitoring
10. In Vivo Imaging Systems Market, by End User
10.1. Introduction
10.2. Academic Research Institutes
10.3. Biotechnology Companies
10.4. Contract Research Organizations
10.5. Pharmaceutical Companies
11. In Vivo Imaging Systems Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. In Vivo Imaging Systems Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. In Vivo Imaging Systems Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Agilent Technologies, Inc.
15.2. Aspect Imaging Ltd.
15.3. Bio-Rad Laboratories, Inc.
15.4. Bruker Corporation
15.5. Canon Medical Systems Corporation
15.6. Carestream Health, Inc.
15.7. FUJIFILM VisualSonics, Inc.
15.8. GE HealthCare Technologies Inc.
15.9. Koninklijke Philips N.V.
15.10. LI-COR Biosciences, Inc.
15.11. Mediso Medical Imaging Systems Ltd.
15.12. MILabs B.V.
15.13. Miltenyi Biotec GmbH
15.14. MR Solutions Ltd.
15.15. PerkinElmer, Inc.
15.16. Promega Corporation
15.17. SCANCO Medical AG
15.18. Siemens Healthineers AG
15.19. Thermo Fisher Scientific Inc.
15.20. TriFoil Imaging, Inc.
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global In Vivo Imaging Systems Market, Years Considered for the Study
FIGURE 2. Global In Vivo Imaging Systems Market, Research Design
FIGURE 3. Global In Vivo Imaging Systems Market, Research Framework
FIGURE 4. Global In Vivo Imaging Systems Market, Data Triangulation
FIGURE 5. Global In Vivo Imaging Systems Market Size, 2017-2032 (USD Million)
FIGURE 6. Global In Vivo Imaging Systems Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global In Vivo Imaging Systems Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global In Vivo Imaging Systems Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 9. Global In Vivo Imaging Systems Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global In Vivo Imaging Systems Market Size, by Application, 2025 vs 2032 (%)
FIGURE 11. Global In Vivo Imaging Systems Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global In Vivo Imaging Systems Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global In Vivo Imaging Systems Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global In Vivo Imaging Systems Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global In Vivo Imaging Systems Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global In Vivo Imaging Systems Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global In Vivo Imaging Systems Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global In Vivo Imaging Systems Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global In Vivo Imaging Systems Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global In Vivo Imaging Systems Market Segmentation & Coverage
TABLE 2. Global In Vivo Imaging Systems Market Size, 2017-2032 (USD Million)
TABLE 3. Global In Vivo Imaging Systems Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Imaging Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Imaging Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Imaging Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Standalone Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Standalone Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Standalone Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Integrated Multimodal Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Integrated Multimodal Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Integrated Multimodal Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Portable And Benchtop Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Portable And Benchtop Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Portable And Benchtop Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Imaging Reagents And Probes Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Imaging Reagents And Probes Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Imaging Reagents And Probes Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Optical Probes Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Optical Probes Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Optical Probes Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Fluorescent Dyes Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Fluorescent Dyes Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Fluorescent Dyes Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Bioluminescent Substrates Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Bioluminescent Substrates Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Bioluminescent Substrates Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Targeted Molecular Probes Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Targeted Molecular Probes Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Targeted Molecular Probes Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Activatable Probes Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Activatable Probes Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Activatable Probes Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Nuclear Tracers Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Nuclear Tracers Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Nuclear Tracers Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global PET Tracers Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global PET Tracers Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global PET Tracers Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global SPECT Tracers Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global SPECT Tracers Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global SPECT Tracers Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global MRI Contrast Agents Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global MRI Contrast Agents Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global MRI Contrast Agents Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global CT Contrast Agents Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global CT Contrast Agents Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global CT Contrast Agents Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Ultrasound Contrast Agents Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Ultrasound Contrast Agents Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Ultrasound Contrast Agents Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Software Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Software Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Software Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Image Acquisition Software Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Image Acquisition Software Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Image Acquisition Software Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Image Analysis Software Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Image Analysis Software Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Image Analysis Software Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global 2D Analysis Tools Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global 2D Analysis Tools Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global 2D Analysis Tools Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global 3D Reconstruction Tools Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global 3D Reconstruction Tools Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global 3D Reconstruction Tools Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Quantification And Kinetic Modeling Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global Quantification And Kinetic Modeling Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global Quantification And Kinetic Modeling Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global Data Management And Reporting Software Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Global Data Management And Reporting Software Market Size, by Group, 2017-2032 (USD Million)
TABLE 72. Global Data Management And Reporting Software Market Size, by Country, 2017-2032 (USD Million)
TABLE 73. Global In Vivo Imaging Systems Market Size, by Technology, 2017-2032 (USD Million)
TABLE 74. Global Computed Tomography Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global Computed Tomography Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global Computed Tomography Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global Cone Beam CT Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Global Cone Beam CT Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. Global Cone Beam CT Market Size, by Country, 2017-2032 (USD Million)
TABLE 80. Global Micro CT Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Global Micro CT Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. Global Micro CT Market Size, by Country, 2017-2032 (USD Million)
TABLE 83. Global Magnetic Resonance Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Global Magnetic Resonance Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 85. Global Magnetic Resonance Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 86. Global Fluorine MRI Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Global Fluorine MRI Market Size, by Group, 2017-2032 (USD Million)
TABLE 88. Global Fluorine MRI Market Size, by Country, 2017-2032 (USD Million)
TABLE 89. Global Proton MRI Market Size, by Region, 2017-2032 (USD Million)
TABLE 90. Global Proton MRI Market Size, by Group, 2017-2032 (USD Million)
TABLE 91. Global Proton MRI Market Size, by Country, 2017-2032 (USD Million)
TABLE 92. Global Optical Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 93. Global Optical Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 94. Global Optical Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 95. Global Bioluminescence Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 96. Global Bioluminescence Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 97. Global Bioluminescence Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 98. Global Fluorescence Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 99. Global Fluorescence Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 100. Global Fluorescence Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 101. Global Positron Emission Tomography Market Size, by Region, 2017-2032 (USD Million)
TABLE 102. Global Positron Emission Tomography Market Size, by Group, 2017-2032 (USD Million)
TABLE 103. Global Positron Emission Tomography Market Size, by Country, 2017-2032 (USD Million)
TABLE 104. Global Ultrasound Market Size, by Region, 2017-2032 (USD Million)
TABLE 105. Global Ultrasound Market Size, by Group, 2017-2032 (USD Million)
TABLE 106. Global Ultrasound Market Size, by Country, 2017-2032 (USD Million)
TABLE 107. Global In Vivo Imaging Systems Market Size, by Application, 2017-2032 (USD Million)
TABLE 108. Global Cardiology Market Size, by Region, 2017-2032 (USD Million)
TABLE 109. Global Cardiology Market Size, by Group, 2017-2032 (USD Million)
TABLE 110. Global Cardiology Market Size, by Country, 2017-2032 (USD Million)
TABLE 111. Global Myocardial Infarction Market Size, by Region, 2017-2032 (USD Million)
TABLE 112. Global Myocardial Infarction Market Size, by Group, 2017-2032 (USD Million)
TABLE 113. Global Myocardial Infarction Market Size, by Country, 2017-2032 (USD Million)
TABLE 114. Global Vascular Diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 115. Global Vascular Diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 116. Global Vascular Diseases Market Size, by Country, 2017-2032 (USD Million)
TABLE 117. Global Drug Discovery Market Size, by Region, 2017-2032 (USD Million)
TABLE 118. Global Drug Discovery Market Size, by Group, 2017-2032 (USD Million)
TABLE 119. Global Drug Discovery Market Size, by Country, 2017-2032 (USD Million)
TABLE 120. Global Pharmacokinetics Market Size, by Region, 2017-2032 (USD Million)
TABLE 121. Global Pharmacokinetics Market Size, by Group, 2017-2032 (USD Million)
TABLE 122. Global Pharmacokinetics Market Size, by Country, 2017-2032 (USD Million)
TABLE 123. Global Target Validation Market Size, by Region, 2017-2032 (USD Million)
TABLE 124. Global Target Validation Market Size, by Group, 2017-2032 (USD Million)
TABLE 125. Global Target Validation Market Size, by Country, 2017-2032 (USD Million)
TABLE 126. Global Neurology Market Size, by Region, 2017-2032 (USD Million)
TABLE 127. Global Neurology Market Size, by Group, 2017-2032 (USD Million)
TABLE 128. Global Neurology Market Size, by Country, 2017-2032 (USD Million)
TABLE 129. Global Neurodegenerative Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 130. Global Neurodegenerative Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 131. Global Neurodegenerative Disease Market Size, by Country, 2017-2032 (USD Million)
TABLE 132. Global Neuroinflammation Market Size, by Region, 2017-2032 (USD Million)
TABLE 133. Global Neuroinflammation Market Size, by Group, 2017-2032 (USD Million)
TABLE 134. Global Neuroinflammation Market Size, by Country, 2017-2032 (USD Million)
TABLE 135. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 136. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 137. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
TABLE 138. Global Tumor Detection Market Size, by Region, 2017-2032 (USD Million)
TABLE 139. Global Tumor Detection Market Size, by Group, 2017-2032 (USD Million)
TABLE 140. Global Tumor Detection Market Size, by Country, 2017-2032 (USD Million)
TABLE 141. Global Tumor Monitoring Market Size, by Region, 2017-2032 (USD Million)
TABLE 142. Global Tumor Monitoring Market Size, by Group, 2017-2032 (USD Million)
TABLE 143. Global Tumor Monitoring Market Size, by Country, 2017-2032 (USD Million)
TABLE 144. Global In Vivo Imaging Systems Market Size, by End User, 2017-2032 (USD Million)
TABLE 145. Global Academic Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 146. Global Academic Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 147. Global Academic Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 148. Global Biotechnology Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 149. Global Biotechnology Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 150. Global Biotechnology Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 151. Global Contract Research Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 152. Global Contract Research Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 153. Global Contract Research Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 154. Global Pharmaceutical Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 155. Global Pharmaceutical Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 156. Global Pharmaceutical Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 157. Global In Vivo Imaging Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 158. Asia-Pacific In Vivo Imaging Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 159. Asia-Pacific In Vivo Imaging Systems Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 160. Asia-Pacific In Vivo Imaging Systems Market Size, by Imaging Systems, 2017-2032 (USD Million)
TABLE 161. Asia-Pacific In Vivo Imaging Systems Market Size, by Imaging Reagents And Probes, 2017-2032 (USD Million)
TABLE 162. Asia-Pacific In Vivo Imaging Systems Market Size, by Optical Probes, 2017-2032 (USD Million)
TABLE 163. Asia-Pacific In Vivo Imaging Systems Market Size, by Nuclear Tracers, 2017-2032 (USD Million)
TABLE 164. Asia-Pacific In Vivo Imaging Systems Market Size, by Software, 2017-2032 (USD Million)
TABLE 165. Asia-Pacific In Vivo Imaging Systems Market Size, by Image Analysis Software, 2017-2032 (USD Million)
TABLE 166. Asia-Pacific In Vivo Imaging Systems Market Size, by Technology, 2017-2032 (USD Million)
TABLE 167. Asia-Pacific In Vivo Imaging Systems Market Size, by Computed Tomography, 2017-2032 (USD Million)
TABLE 168. Asia-Pacific In Vivo Imaging Systems Market Size, by Magnetic Resonance Imaging, 2017-2032 (USD Million)
TABLE 169. Asia-Pacific In Vivo Imaging Systems Market Size, by Optical Imaging, 2017-2032 (USD Million)
TABLE 170. Asia-Pacific In Vivo Imaging Systems Market Size, by Application, 2017-2032 (USD Million)
TABLE 171. Asia-Pacific In Vivo Imaging Systems Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 172. Asia-Pacific In Vivo Imaging Systems Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 173. Asia-Pacific In Vivo Imaging Systems Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 174. Asia-Pacific In Vivo Imaging Systems Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 175. Asia-Pacific In Vivo Imaging Systems Market Size, by End User, 2017-2032 (USD Million)
TABLE 176. North America In Vivo Imaging Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 177. North America In Vivo Imaging Systems Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 178. North America In Vivo Imaging Systems Market Size, by Imaging Systems, 2017-2032 (USD Million)
TABLE 179. North America In Vivo Imaging Systems Market Size, by Imaging Reagents And Probes, 2017-2032 (USD Million)
TABLE 180. North America In Vivo Imaging Systems Market Size, by Optical Probes, 2017-2032 (USD Million)
TABLE 181. North America In Vivo Imaging Systems Market Size, by Nuclear Tracers, 2017-2032 (USD Million)
TABLE 182. North America In Vivo Imaging Systems Market Size, by Software, 2017-2032 (USD Million)
TABLE 183. North America In Vivo Imaging Systems Market Size, by Image Analysis Software, 2017-2032 (USD Million)
TABLE 184. North America In Vivo Imaging Systems Market Size, by Technology, 2017-2032 (USD Million)
TABLE 185. North America In Vivo Imaging Systems Market Size, by Computed Tomography, 2017-2032 (USD Million)
TABLE 186. North America In Vivo Imaging Systems Market Size, by Magnetic Resonance Imaging, 2017-2032 (USD Million)
TABLE 187. North America In Vivo Imaging Systems Market Size, by Optical Imaging, 2017-2032 (USD Million)
TABLE 188. North America In Vivo Imaging Systems Market Size, by Application, 2017-2032 (USD Million)
TABLE 189. North America In Vivo Imaging Systems Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 190. North America In Vivo Imaging Systems Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 191. North America In Vivo Imaging Systems Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 192. North America In Vivo Imaging Systems Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 193. North America In Vivo Imaging Systems Market Size, by End User, 2017-2032 (USD Million)
TABLE 194. Latin America In Vivo Imaging Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 195. Latin America In Vivo Imaging Systems Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 196. Latin America In Vivo Imaging Systems Market Size, by Imaging Systems, 2017-2032 (USD Million)
TABLE 197. Latin America In Vivo Imaging Systems Market Size, by Imaging Reagents And Probes, 2017-2032 (USD Million)
TABLE 198. Latin America In Vivo Imaging Systems Market Size, by Optical Probes, 2017-2032 (USD Million)
TABLE 199. Latin America In Vivo Imaging Systems Market Size, by Nuclear Tracers, 2017-2032 (USD Million)
TABLE 200. Latin America In Vivo Imaging Systems Market Size, by Software, 2017-2032 (USD Million)
TABLE 201. Latin America In Vivo Imaging Systems Market Size, by Image Analysis Software, 2017-2032 (USD Million)
TABLE 202. Latin America In Vivo Imaging Systems Market Size, by Technology, 2017-2032 (USD Million)
TABLE 203. Latin America In Vivo Imaging Systems Market Size, by Computed Tomography, 2017-2032 (USD Million)
TABLE 204. Latin America In Vivo Imaging Systems Market Size, by Magnetic Resonance Imaging, 2017-2032 (USD Million)
TABLE 205. Latin America In Vivo Imaging Systems Market Size, by Optical Imaging, 2017-2032 (USD Million)
TABLE 206. Latin America In Vivo Imaging Systems Market Size, by Application, 2017-2032 (USD Million)
TABLE 207. Latin America In Vivo Imaging Systems Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 208. Latin America In Vivo Imaging Systems Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 209. Latin America In Vivo Imaging Systems Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 210. Latin America In Vivo Imaging Systems Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 211. Latin America In Vivo Imaging Systems Market Size, by End User, 2017-2032 (USD Million)
TABLE 212. Europe In Vivo Imaging Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 213. Europe In Vivo Imaging Systems Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 214. Europe In Vivo Imaging Systems Market Size, by Imaging Systems, 2017-2032 (USD Million)
TABLE 215. Europe In Vivo Imaging Systems Market Size, by Imaging Reagents And Probes, 2017-2032 (USD Million)
TABLE 216. Europe In Vivo Imaging Systems Market Size, by Optical Probes, 2017-2032 (USD Million)
TABLE 217. Europe In Vivo Imaging Systems Market Size, by Nuclear Tracers, 2017-2032 (USD Million)
TABLE 218. Europe In Vivo Imaging Systems Market Size, by Software, 2017-2032 (USD Million)
TABLE 219. Europe In Vivo Imaging Systems Market Size, by Image Analysis Software, 2017-2032 (USD Million)
TABLE 220. Europe In Vivo Imaging Systems Market Size, by Technology, 2017-2032 (USD Million)
TABLE 221. Europe In Vivo Imaging Systems Market Size, by Computed Tomography, 2017-2032 (USD Million)
TABLE 222. Europe In Vivo Imaging Systems Market Size, by Magnetic Resonance Imaging, 2017-2032 (USD Million)
TABLE 223. Europe In Vivo Imaging Systems Market Size, by Optical Imaging, 2017-2032 (USD Million)
TABLE 224. Europe In Vivo Imaging Systems Market Size, by Application, 2017-2032 (USD Million)
TABLE 225. Europe In Vivo Imaging Systems Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 226. Europe In Vivo Imaging Systems Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 227. Europe In Vivo Imaging Systems Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 228. Europe In Vivo Imaging Systems Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 229. Europe In Vivo Imaging Systems Market Size, by End User, 2017-2032 (USD Million)
TABLE 230. Middle East In Vivo Imaging Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 231. Middle East In Vivo Imaging Systems Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 232. Middle East In Vivo Imaging Systems Market Size, by Imaging Systems, 2017-2032 (USD Million)
TABLE 233. Middle East In Vivo Imaging Systems Market Size, by Imaging Reagents And Probes, 2017-2032 (USD Million)
TABLE 234. Middle East In Vivo Imaging Systems Market Size, by Optical Probes, 2017-2032 (USD Million)
TABLE 235. Middle East In Vivo Imaging Systems Market Size, by Nuclear Tracers, 2017-2032 (USD Million)
TABLE 236. Middle East In Vivo Imaging Systems Market Size, by Software, 2017-2032 (USD Million)
TABLE 237. Middle East In Vivo Imaging Systems Market Size, by Image Analysis Software, 2017-2032 (USD Million)
TABLE 238. Middle East In Vivo Imaging Systems Market Size, by Technology, 2017-2032 (USD Million)
TABLE 239. Middle East In Vivo Imaging Systems Market Size, by Computed Tomography, 2017-2032 (USD Million)
TABLE 240. Middle East In Vivo Imaging Systems Market Size, by Magnetic Resonance Imaging, 2017-2032 (USD Million)
TABLE 241. Middle East In Vivo Imaging Systems Market Size, by Optical Imaging, 2017-2032 (USD Million)
TABLE 242. Middle East In Vivo Imaging Systems Market Size, by Application, 2017-2032 (USD Million)
TABLE 243. Middle East In Vivo Imaging Systems Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 244. Middle East In Vivo Imaging Systems Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 245. Middle East In Vivo Imaging Systems Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 246. Middle East In Vivo Imaging Systems Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 247. Middle East In Vivo Imaging Systems Market Size, by End User, 2017-2032 (USD Million)
TABLE 248. Africa In Vivo Imaging Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 249. Africa In Vivo Imaging Systems Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 250. Africa In Vivo Imaging Systems Market Size, by Imaging Systems, 2017-2032 (USD Million)
TABLE 251. Africa In Vivo Imaging Systems Market Size, by Imaging Reagents And Probes, 2017-2032 (USD Million)
TABLE 252. Africa In Vivo Imaging Systems Market Size, by Optical Probes, 2017-2032 (USD Million)
TABLE 253. Africa In Vivo Imaging Systems Market Size, by Nuclear Tracers, 2017-2032 (USD Million)
TABLE 254. Africa In Vivo Imaging Systems Market Size, by Software, 2017-2032 (USD Million)
TABLE 255. Africa In Vivo Imaging Systems Market Size, by Image Analysis Software, 2017-2032 (USD Million)
TABLE 256. Africa In Vivo Imaging Systems Market Size, by Technology, 2017-2032 (USD Million)
TABLE 257. Africa In Vivo Imaging Systems Market Size, by Computed Tomography, 2017-2032 (USD Million)
TABLE 258. Africa In Vivo Imaging Systems Market Size, by Magnetic Resonance Imaging, 2017-2032 (USD Million)
TABLE 259. Africa In Vivo Imaging Systems Market Size, by Optical Imaging, 2017-2032 (USD Million)
TABLE 260. Africa In Vivo Imaging Systems Market Size, by Application, 2017-2032 (USD Million)
TABLE 261. Africa In Vivo Imaging Systems Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 262. Africa In Vivo Imaging Systems Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 263. Africa In Vivo Imaging Systems Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 264. Africa In Vivo Imaging Systems Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 265. Africa In Vivo Imaging Systems Market Size, by End User, 2017-2032 (USD Million)
TABLE 266. Global In Vivo Imaging Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 267. ASEAN In Vivo Imaging Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 268. ASEAN In Vivo Imaging Systems Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 269. ASEAN In Vivo Imaging Systems Market Size, by Imaging Systems, 2017-2032 (USD Million)
TABLE 270. ASEAN In Vivo Imaging Systems Market Size, by Imaging Reagents And Probes, 2017-2032 (USD Million)
TABLE 271. ASEAN In Vivo Imaging Systems Market Size, by Optical Probes, 2017-2032 (USD Million)
TABLE 272. ASEAN In Vivo Imaging Systems Market Size, by Nuclear Tracers, 2017-2032 (USD Million)
TABLE 273. ASEAN In Vivo Imaging Systems Market Size, by Software, 2017-2032 (USD Million)
TABLE 274. ASEAN In Vivo Imaging Systems Market Size, by Image Analysis Software, 2017-2032 (USD Million)
TABLE 275. ASEAN In Vivo Imaging Systems Market Size, by Technology, 2017-2032 (USD Million)
TABLE 276. ASEAN In Vivo Imaging Systems Market Size, by Computed Tomography, 2017-2032 (USD Million)
TABLE 277. ASEAN In Vivo Imaging Systems Market Size, by Magnetic Resonance Imaging, 2017-2032 (USD Million)
TABLE 278. ASEAN In Vivo Imaging Systems Market Size, by Optical Imaging, 2017-2032 (USD Million)
TABLE 279. ASEAN In Vivo Imaging Systems Market Size, by Application, 2017-2032 (USD Million)
TABLE 280. ASEAN In Vivo Imaging Systems Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 281. ASEAN In Vivo Imaging Systems Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 282. ASEAN In Vivo Imaging Systems Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 283. ASEAN In Vivo Imaging Systems Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 284. ASEAN In Vivo Imaging Systems Market Size, by End User, 2017-2032 (USD Million)
TABLE 285. GCC In Vivo Imaging Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 286. GCC In Vivo Imaging Systems Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 287. GCC In Vivo Imaging Systems Market Size, by Imaging Systems, 2017-2032 (USD Million)
TABLE 288. GCC In Vivo Imaging Systems Market Size, by Imaging Reagents And Probes, 2017-2032 (USD Million)
TABLE 289. GCC In Vivo Imaging Systems Market Size, by Optical Probes, 2017-2032 (USD Million)
TABLE 290. GCC In Vivo Imaging Systems Market Size, by Nuclear Tracers, 2017-2032 (USD Million)
TABLE 291. GCC In Vivo Imaging Systems Market Size, by Software, 2017-2032 (USD Million)
TABLE 292. GCC In Vivo Imaging Systems Market Size, by Image Analysis Software, 2017-2032 (USD Million)
TABLE 293. GCC In Vivo Imaging Systems Market Size, by Technology, 2017-2032 (USD Million)
TABLE 294. GCC In Vivo Imaging Systems Market Size, by Computed Tomography, 2017-2032 (USD Million)
TABLE 295. GCC In Vivo Imaging Systems Market Size, by Magnetic Resonance Imaging, 2017-2032 (USD Million)
TABLE 296. GCC In Vivo Imaging Systems Market Size, by Optical Imaging, 2017-2032 (USD Million)
TABLE 297. GCC In Vivo Imaging Systems Market Size, by Application, 2017-2032 (USD Million)
TABLE 298. GCC In Vivo Imaging Systems Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 299. GCC In Vivo Imaging Systems Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 300. GCC In Vivo Imaging Systems Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 301. GCC In Vivo Imaging Systems Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 302. GCC In Vivo Imaging Systems Market Size, by End User, 2017-2032 (USD Million)
TABLE 303. European Union In Vivo Imaging Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 304. European Union In Vivo Imaging Systems Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 305. European Union In Vivo Imaging Systems Market Size, by Imaging Systems, 2017-2032 (USD Million)
TABLE 306. European Union In Vivo Imaging Systems Market Size, by Imaging Reagents And Probes, 2017-2032 (USD Million)
TABLE 307. European Union In Vivo Imaging Systems Market Size, by Optical Probes, 2017-2032 (USD Million)
TABLE 308. European Union In Vivo Imaging Systems Market Size, by Nuclear Tracers, 2017-2032 (USD Million)
TABLE 309. European Union In Vivo Imaging Systems Market Size, by Software, 2017-2032 (USD Million)
TABLE 310. European Union In Vivo Imaging Systems Market Size, by Image Analysis Software, 2017-2032 (USD Million)
TABLE 311. European Union In Vivo Imaging Systems Market Size, by Technology, 2017-2032 (USD Million)
TABLE 312. European Union In Vivo Imaging Systems Market Size, by Computed Tomography, 2017-2032 (USD Million)
TABLE 313. European Union In Vivo Imaging Systems Market Size, by Magnetic Resonance Imaging, 2017-2032 (USD Million)
TABLE 314. European Union In Vivo Imaging Systems Market Size, by Optical Imaging, 2017-2032 (USD Million)
TABLE 315. European Union In Vivo Imaging Systems Market Size, by Application, 2017-2032 (USD Million)
TABLE 316. European Union In Vivo Imaging Systems Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 317. European Union In Vivo Imaging Systems Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 318. European Union In Vivo Imaging Systems Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 319. European Union In Vivo Imaging Systems Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 320. European Union In Vivo Imaging Systems Market Size, by End User, 2017-2032 (USD Million)
TABLE 321. BRICS In Vivo Imaging Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 322. BRICS In Vivo Imaging Systems Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 323. BRICS In Vivo Imaging Systems Market Size, by Imaging Systems, 2017-2032 (USD Million)
TABLE 324. BRICS In Vivo Imaging Systems Market Size, by Imaging Reagents And Probes, 2017-2032 (USD Million)
TABLE 325. BRICS In Vivo Imaging Systems Market Size, by Optical Probes, 2017-2032 (USD Million)
TABLE 326. BRICS In Vivo Imaging Systems Market Size, by Nuclear Tracers, 2017-2032 (USD Million)
TABLE 327. BRICS In Vivo Imaging Systems Market Size, by Software, 2017-2032 (USD Million)
TABLE 328. BRICS In Vivo Imaging Systems Market Size, by Image Analysis Software, 2017-2032 (USD Million)
TABLE 329. BRICS In Vivo Imaging Systems Market Size, by Technology, 2017-2032 (USD Million)
TABLE 330. BRICS In Vivo Imaging Systems Market Size, by Computed Tomography, 2017-2032 (USD Million)
TABLE 331. BRICS In Vivo Imaging Systems Market Size, by Magnetic Resonance Imaging, 2017-2032 (USD Million)
TABLE 332. BRICS In Vivo Imaging Systems Market Size, by Optical Imaging, 2017-2032 (USD Million)
TABLE 333. BRICS In Vivo Imaging Systems Market Size, by Application, 2017-2032 (USD Million)
TABLE 334. BRICS In Vivo Imaging Systems Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 335. BRICS In Vivo Imaging Systems Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 336. BRICS In Vivo Imaging Systems Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 337. BRICS In Vivo Imaging Systems Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 338. BRICS In Vivo Imaging Systems Market Size, by End User, 2017-2032 (USD Million)
TABLE 339. G7 In Vivo Imaging Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 340. G7 In Vivo Imaging Systems Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 341. G7 In Vivo Imaging Systems Market Size, by Imaging Systems, 2017-2032 (USD Million)
TABLE 342. G7 In Vivo Imaging Systems Market Size, by Imaging Reagents And Probes, 2017-2032 (USD Million)
TABLE 343. G7 In Vivo Imaging Systems Market Size, by Optical Probes, 2017-2032 (USD Million)
TABLE 344. G7 In Vivo Imaging Systems Market Size, by Nuclear Tracers, 2017-2032 (USD Million)
TABLE 345. G7 In Vivo Imaging Systems Market Size, by Software, 2017-2032 (USD Million)
TABLE 346. G7 In Vivo Imaging Systems Market Size, by Image Analysis Software, 2017-2032 (USD Million)
TABLE 347. G7 In Vivo Imaging Systems Market Size, by Technology, 2017-2032 (USD Million)
TABLE 348. G7 In Vivo Imaging Systems Market Size, by Computed Tomography, 2017-2032 (USD Million)
TABLE 349. G7 In Vivo Imaging Systems Market Size, by Magnetic Resonance Imaging, 2017-2032 (USD Million)
TABLE 350. G7 In Vivo Imaging Systems Market Size, by O

Companies Mentioned

  • Agilent Technologies, Inc.
  • Aspect Imaging Ltd.
  • Bio-Rad Laboratories, Inc.
  • Bruker Corporation
  • Canon Medical Systems Corporation
  • Carestream Health, Inc.
  • FUJIFILM VisualSonics, Inc.
  • GE HealthCare Technologies Inc.
  • Koninklijke Philips N.V.
  • LI-COR Biosciences, Inc.
  • Mediso Medical Imaging Systems Ltd.
  • MILabs B.V.
  • Miltenyi Biotec GmbH
  • MR Solutions Ltd.
  • PerkinElmer, Inc.
  • Promega Corporation
  • SCANCO Medical AG
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • TriFoil Imaging, Inc.

Related Topics

Related Reports

Optical Preclinical Imaging Market - Global Forecast 2026-2032 - Product Image

Optical Preclinical Imaging Market - Global Forecast 2026-2032

  • Report
  • 193 Pages
  • Global
From
Full-Spectrum Fluorescence In Vivo Imaging System Market - Global Forecast 2026-2032 - Product Image

Full-Spectrum Fluorescence In Vivo Imaging System Market - Global Forecast 2026-2032

  • Report
  • 191 Pages
  • Global
From
Preclinical Imaging (In-VIVO) - Global Strategic Business Report - Product Image

Preclinical Imaging (In-VIVO) - Global Strategic Business Report

  • Report
  • 192 Pages
  • Global
From
In Vivo Contract Research Organization (CRO) - Global Strategic Business Report - Product Image

In Vivo Contract Research Organization (CRO) - Global Strategic Business Report

  • Report
  • 220 Pages
  • Global
From
Preclinical Imaging Market Report 2026 - Product Image

Preclinical Imaging Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.